Literature DB >> 6295719

Steps in the phosphorylation of the high mannose oligosaccharides of lysosomal enzymes.

S Kornfeld, M L Reitman, A Varki, D Goldberg, C A Gabel.   

Abstract

The phosphomannosyl recognition marker of acid hydrolases, which mediates their translocation to lysosomes, has been shown to be synthesized in two steps. First, N-acetylglucosamine 1-phosphate is transferred to an acceptor mannose by UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase, resulting in a phosphate group in diester linkage between the outer N-acetylglucosamine and the inner mannose. Next, an a-N-acetylglucosaminyl phosphodiesterase removes the N-acetylglucosamine, leaving the phosphate in monoester linkage with the underlying mannose residue. This exposed phosphomannosyl residue serves as the essential component of a recognition marker which leads to binding to high-affinity receptors and subsequent translocation to lysosomes. We propose that the first enzyme in this scheme, N-acetylglucosaminylphosphotransferase, catalyses the initial, determining step by which newly synthesized acid hydrolases are distinguished from other newly synthesized glycoproteins and thus are eventually targeted to lysosomes. The absence of this enzyme activity, as in inclusion-cell (I-cell) disease and pseudo-Hurler polydystrophy, precludes the receptor-mediated targeting of newly synthesized acid hydrolases to lysosomes. As a consequence, the enzymes are secreted into the extracellular milieu.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6295719     DOI: 10.1002/9780470720745.ch8

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  13 in total

Review 1.  New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010 Mar-Apr

2.  Introduction of Stuart Kornfeld.

Authors:  Ajit Varki
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

3.  Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Drug Deliv Transl Res       Date:  2012-06-01       Impact factor: 4.617

4.  Discovery of the cellular and molecular basis of cholesterol control.

Authors:  Randy Schekman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-23       Impact factor: 11.205

5.  Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease.

Authors:  Janet Hsu; Daniel Serrano; Tridib Bhowmick; Kishan Kumar; Yang Shen; Yuan Chia Kuo; Carmen Garnacho; Silvia Muro
Journal:  J Control Release       Date:  2010-11-01       Impact factor: 9.776

Review 6.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.

Authors:  Melani Solomon; Silvia Muro
Journal:  Adv Drug Deliv Rev       Date:  2017-05-11       Impact factor: 15.470

Review 7.  Endocytosis and the recycling of plasma membrane.

Authors:  R M Steinman; I S Mellman; W A Muller; Z A Cohn
Journal:  J Cell Biol       Date:  1983-01       Impact factor: 10.539

8.  Posttranslational processing of Uukuniemi virus glycoproteins G1 and G2.

Authors:  E Kuismanen
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

9.  Heterozygosity for phosphodiester glycosidase deficiency: a novel human mutation of lysosomal enzyme processing.

Authors:  D Alexander; M Deeb; F Talj
Journal:  Hum Genet       Date:  1986-05       Impact factor: 4.132

10.  Cathepsin-Mediated Alterations in TGFß-Related Signaling Underlie Disrupted Cartilage and Bone Maturation Associated With Impaired Lysosomal Targeting.

Authors:  Heather Flanagan-Steet; Megan Aarnio; Brian Kwan; Pierre Guihard; Aaron Petrey; Mark Haskins; Frederic Blanchard; Richard Steet
Journal:  J Bone Miner Res       Date:  2015-10-13       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.